**Part 2**

**Research in Oral Health** 

110 Oral Health Care – Pediatric, Research, Epidemiology and Clinical Practices

[58] American Cleft Palate-Craniofacial Association (2009). Parameters for evaluation and

[59] Yazdy MM, Autry AR, Honein MA, et al (2008). Use of special education services by children with orofacial clefts. Birth Defects Res A Clin Mol Teratol. 82:147-54. [60] Parkin DM, Bray F, Ferlay J, et al (2005): Global cancer statistics, 2002. CA: Cancer

[61] Mehrotra R, Pandya S, Chaudhary AK, et al (2008): Prevalence of oral pre-malignant

[62] Conrad EU, Bradford L, Chansky HA (1996). Pediatric soft-tissue sarcomas. Orthop Clin

[63] Ludwig JA (2008). Personalized therapy of sarcomas: integration of biomarkers for

[64] Ordóñez JL, Martins AS, Osuna D, et al (2008). Targeting sarcomas: therapeutic targets

[65] Enneking WF (1984). Staging of musculoskeletal neoplasms. In: Uhthoff HK, ed. Current

[66] Potter DA, Glenn J, Kinsella T (1985). Patterns of recurrence in patients with high-grade

[67] Gustafson P (1994). Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.

[68] Costen JB (1997). A syndrome of ear and sinus symptoms dependent upon disturbed

[69] Michael LA (1997). Jaws revisited: Costen's syndrome. Ann Otol Rhinol Laryngol 106

[70] van der Meulen MJ, Ohrbach R, Aartman IH, et al (2010). Temporomandibular disorder

[71] Crider A, Glaros AG, Gevirtz RN (2005). Efficacy of biofeedback-based treatments for temporomandibular disorders. Appl Psychophysiol Biofeedback 30 (4): 333-45. [72] Drangsholt, M; Truelove, EL (2001). Trigeminal neuralgia mistaken as

[73] Vickers ER, Cousins MJ (2000). Neuropathic orofacial pain. Part 2-Diagnostic procedures, treatment guidelines and case reports. Aust Endod J 26 (2): 53–63.

temporomandibular disorder. J Evid Base Dent Pract.1 (1): 41–50.

and their rational. Semin Diagn Pathol. 25 (4):304-16.

soft-tissue sarcomas. J Clin Oncol. 3(3):353-66.

Acta Orthop Scand Suppl. 259:1-31.

edition. Chapel Hill, NC. P. 1-34.

Journal for Clinicians. 55:74-108.

Cancer Prev. 9(2):263-5.

North Am. 27 (3):655-64.

Springer-Verlag.

805–19.

367–372.

(10 Pt 1): 820–2.

37.

treatment of patients with cleft lip/palate or other craniofacial anomalies. Revised

and malignant lesions at a tertiary level hospital in Allahabad, India. Asian Pac J

improved diagnosis, prognosis, and therapy selection. Curr Oncol Rep.10 (4):329-

Concepts of Diagnosis and Treatment of Bone and Soft Tissue Tumors. Heidelberg*:*

function of the temporomandibular joint. Ann Otol Rhinol Laryngol 106 (10 Pt 1):

patients' illness beliefs and self-efficacy related to bruxism. J Orofac Pain 24 (4):

**6** 

*Brazil* 

and Ana Maria Trindade Grégio

**Antidepressants: Side Effects in the Mouth** 

*Pontifícia Universidade Católica do Paraná & Universidade Federal do Paraná* 

Patrícia Del Vigna de Ameida, Aline Cristina Batista Rodrigues Johann, Luciana Reis de Azevedo Alanis, Antônio Adilson Soares de Lima

Oral reactions to medications are common and affect patients' quality of life. Almost all classes of drugs, particularly those used continuously, such as antidepressants, antihypertensives, anxiolytics, hypnotics, diuretics, antipsychotics among others, including vitamins, minerals and phyto-pharmaceuticals, may cause oral alterations. If not suitably treated, these may aggravate the patient's general state of health and affect his/her oral health (Lamy, 1984; Smith & Burtner, 1994; Rees, 1998; Ciancio, 2004; American Dental

Prescribed and over-the-counter medications are frequently used in large quantities and by many adults, particularly by those over the age of 65 years. The abusive use of drugs, mainly by elderly patients, may generate oral side effects (Lamy, 1984; Ciancio, 2004; ADA, 2005). The number of prescriptions in the USA is mainly due to the therapeutic advances in the treatment of various medical conditions and the increase in the geriatric population. Josephe et al. (2003) observed that 21% of the 1,800 patient dental records reviewed showed antidepressant use. It is suspected that the prevalence of oral lesions increases in direct relation to the increase in the use of necessary drugs, mainly to control chronic diseases. Over 200 drugs are involved in adverse reactions and side effects on oral tissues. Smith & Burtner (1994) founded as oral side-effects of the most frequently prescribed drugs: dry

Xerostomia, a subjective dry mouth sensation, is a side effect of around 400 medications. Moreover, it is one of the major problems in the USA at present, affecting millions of persons. Diminishment or absence of saliva may affect the emotional well being, cause significant morbidity and a reduction in the patient's quality of life (Ciancio, 2004; Fox et al., 1985; Sreebny & Schwartz, 1986; Sreebny & Valdini, 1987; Butt, 1991; Guggenheimer & Moore, 2003). Thus, a dental and medical record of the patient is necessary, with regular updating of the prescribed medications, because of the potential side effects of drugs and interactions among them. It is also important for dentists to know about the problems related to medication and the impact of this on diagnosis and the treatment plan (Keene et al., 2003).

Psychotropic drugs are those that act on the central nervous system (SNC) producing

alterations in behaviour, mood and cognition, and that may lead to dependence.

**1. Introduction** 

**2. Antidepressant** 

Association [ADA], 2005; Scelza et al., 2010).

mouth (80.5%), dysgeusia (47.5%) and stomatitis (33.9%).
